vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and OXFORD INDUSTRIES INC (OXM). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $307.3M, roughly 1.6× OXFORD INDUSTRIES INC). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -20.7%, a 27.5% gap on every dollar of revenue. On growth, OXFORD INDUSTRIES INC posted the faster year-over-year revenue change (-0.2% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -3.0%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Oxford Industries, Inc. is a publicly traded clothing company in the United States that specializes in high-end clothing and apparel. The company carries many major labels, including Tommy Bahama, Lilly Pulitzer, Johnny Was and Southern Tide.
MD vs OXM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $307.3M |
| Net Profit | $33.7M | $-63.7M |
| Gross Margin | — | 60.3% |
| Operating Margin | 9.9% | -27.7% |
| Net Margin | 6.8% | -20.7% |
| Revenue YoY | -1.7% | -0.2% |
| Net Profit YoY | 10.5% | -1517.6% |
| EPS (diluted) | $0.40 | $-4.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $307.3M | ||
| Q3 25 | $492.9M | $403.1M | ||
| Q2 25 | $468.8M | $392.9M | ||
| Q1 25 | $458.4M | — | ||
| Q4 24 | $502.4M | $308.0M | ||
| Q3 24 | $511.2M | $419.9M | ||
| Q2 24 | $504.3M | $398.2M | ||
| Q1 24 | $495.1M | $404.4M |
| Q4 25 | $33.7M | $-63.7M | ||
| Q3 25 | $71.7M | $16.7M | ||
| Q2 25 | $39.3M | $26.2M | ||
| Q1 25 | $20.7M | — | ||
| Q4 24 | $30.5M | $-3.9M | ||
| Q3 24 | $19.4M | $40.6M | ||
| Q2 24 | $-153.0M | $38.4M | ||
| Q1 24 | $4.0M | $-60.1M |
| Q4 25 | — | 60.3% | ||
| Q3 25 | — | 61.4% | ||
| Q2 25 | — | 64.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 63.1% | ||
| Q3 24 | — | 63.1% | ||
| Q2 24 | — | 64.9% | ||
| Q1 24 | — | 60.9% |
| Q4 25 | 9.9% | -27.7% | ||
| Q3 25 | 13.8% | 6.3% | ||
| Q2 25 | 12.8% | 9.2% | ||
| Q1 25 | 7.0% | — | ||
| Q4 24 | 7.8% | -2.0% | ||
| Q3 24 | 6.6% | 12.5% | ||
| Q2 24 | -31.3% | 13.2% | ||
| Q1 24 | 3.2% | -20.1% |
| Q4 25 | 6.8% | -20.7% | ||
| Q3 25 | 14.5% | 4.1% | ||
| Q2 25 | 8.4% | 6.7% | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 6.1% | -1.3% | ||
| Q3 24 | 3.8% | 9.7% | ||
| Q2 24 | -30.3% | 9.6% | ||
| Q1 24 | 0.8% | -14.9% |
| Q4 25 | $0.40 | $-4.28 | ||
| Q3 25 | $0.84 | $1.12 | ||
| Q2 25 | $0.46 | $1.70 | ||
| Q1 25 | $0.24 | — | ||
| Q4 24 | $0.37 | $-0.25 | ||
| Q3 24 | $0.23 | $2.57 | ||
| Q2 24 | $-1.84 | $2.42 | ||
| Q1 24 | $0.05 | $-3.72 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $8.0M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $528.0M |
| Total Assets | $2.2B | $1.3B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $8.0M | ||
| Q3 25 | $340.1M | $6.9M | ||
| Q2 25 | $224.7M | $8.2M | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | $7.0M | ||
| Q3 24 | $103.8M | $18.4M | ||
| Q2 24 | $19.4M | $7.7M | ||
| Q1 24 | $8.0M | $7.6M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $29.0M |
| Q4 25 | $865.9M | $528.0M | ||
| Q3 25 | $890.7M | $597.1M | ||
| Q2 25 | $833.8M | $592.4M | ||
| Q1 25 | $789.2M | — | ||
| Q4 24 | $764.9M | $612.2M | ||
| Q3 24 | $732.5M | $621.6M | ||
| Q2 24 | $706.5M | $592.9M | ||
| Q1 24 | $856.2M | $560.9M |
| Q4 25 | $2.2B | $1.3B | ||
| Q3 25 | $2.2B | $1.3B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.2B | $1.2B | ||
| Q3 24 | $2.1B | $1.2B | ||
| Q2 24 | $2.0B | $1.2B | ||
| Q1 24 | $2.2B | $1.1B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.05× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $-9.1M |
| Free Cash FlowOCF − Capex | — | $-47.9M |
| FCF MarginFCF / Revenue | — | -15.6% |
| Capex IntensityCapex / Revenue | — | 12.6% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-79.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $-9.1M | ||
| Q3 25 | $137.3M | $83.5M | ||
| Q2 25 | $137.2M | $-3.9M | ||
| Q1 25 | $-117.5M | — | ||
| Q4 24 | $133.0M | $-18.2M | ||
| Q3 24 | $91.8M | $88.8M | ||
| Q2 24 | $107.0M | $32.9M | ||
| Q1 24 | $-125.2M | $74.9M |
| Q4 25 | — | $-47.9M | ||
| Q3 25 | — | $52.3M | ||
| Q2 25 | — | $-27.4M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-56.9M | ||
| Q3 24 | — | $47.2M | ||
| Q2 24 | — | $21.0M | ||
| Q1 24 | — | $55.3M |
| Q4 25 | — | -15.6% | ||
| Q3 25 | — | 13.0% | ||
| Q2 25 | — | -7.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -18.5% | ||
| Q3 24 | — | 11.2% | ||
| Q2 24 | — | 5.3% | ||
| Q1 24 | — | 13.7% |
| Q4 25 | — | 12.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 6.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 12.6% | ||
| Q3 24 | — | 9.9% | ||
| Q2 24 | — | 3.0% | ||
| Q1 24 | — | 4.8% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | 5.00× | ||
| Q2 25 | 3.49× | -0.15× | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 2.19× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
OXM
| Sales Channel Retail | $162.9M | 53% |
| Sales Channel Wholesale | $61.3M | 20% |
| Johnny Was | $45.4M | 15% |
| Sales Channel Food And Beverage | $29.3M | 10% |
| Other Foreign Countries | $9.0M | 3% |
